Price: 0 uah
Checkout
Phenylpiracetam is one of the most potent representatives of the racetam class. This water-soluble nootropic compound combines the cognitive properties of classic racetams with a moderate stimulating effect, making it widely used to support mental performance, focus, memory, and physical endurance.
Unlike most nootropics, Phenylpiracetam affects not only cognitive functions but also helps the body better tolerate significant physical exertion, fatigue, and even cold temperatures.
Phenylpiracetam is a nootropic substance of the racetam class, created by modifying the piracetam molecule. The chemical name of the compound is (R,S)-2-(2-oxo-4-phenylpyrrolidin-1-yl) acetamide.
It was synthesized in 1983 by Russian scientists. The primary goal of its creation was to obtain a nootropic compound capable of simultaneously improving cognitive functions and increasing human physical endurance under extreme conditions.
The key difference from piracetam was the addition of a phenyl group to the molecule. This modification significantly improved the pharmacological properties of the substance, increased its bioavailability, and allowed it to penetrate the blood-brain barrier more rapidly. As a result, Phenylpiracetam works much more effectively even in small doses.
Today, it is considered one of the strongest representatives of the racetam family. Many users describe it as a combination of a classic nootropic and a mild psychostimulant without most of the undesirable effects characteristic of traditional stimulant drugs.
The first studies of Phenylpiracetam were conducted in the Soviet Union as part of the space program. Scientists were tasked with creating a supplement that would help astronauts maintain high mental performance, focus, and physical work capacity during long space missions.
Later, the drug began to be used not only in space medicine but also in clinical practice. In Russia and some Eastern European countries, it was used as a treatment for various cognitive and neurological impairments.
Due to its high bioavailability, Phenylpiracetam is rapidly absorbed after ingestion and penetrates the central nervous system. Most users note the onset of the first effects within a relatively short period after taking it.
Most frequently, the drug is used for:
Despite a similar chemical baseline, Phenylpiracetam has several important advantages over classic piracetam.
Due to these properties, many researchers estimate its activity to be dozens of times higher than that of piracetam, though the exact level of efficacy depends on individual body characteristics and conditions of use.
Phenylpiracetam acts comprehensively, affecting several neurotransmitter systems at once that are responsible for memory, attention, thinking speed, learning, and psychoemotional state. Unlike many stimulants, its action is not limited to a short-term energy spike. The main effect is to improve the efficiency of nerve impulse transmission between neurons and optimize brain function.
Based on experimental research results, Phenylpiracetam can influence the density of specific neurotransmitter receptors, improve cerebral blood circulation, and increase the nervous system's resilience to physical and psychoemotional stress.
One of the main features of Phenylpiracetam is its ability to combine a nootropic effect with a moderate psychostimulating action. The drug increases alertness, improves concentration, and promotes faster decision-making without sudden drops in energy.
It is hypothesized that this effect is associated with an increase in the number of receptors for dopamine, acetylcholine, GABA, and NMDA. The more active receptors available, the more effectively neurotransmitters can perform their functions.
This is why many users describe the action of Phenylpiracetam as "cleaner" compared to classic stimulants. Instead of a sharp spike in energy, people more frequently report stable focus, improved clarity of thought, and sustained high productivity for several hours.
Nerve cells communicate with each other using special chemicals called neurotransmitters. For a signal to be transmitted, the neurotransmitter molecule must bind to its corresponding receptor.
Studies indicate that Phenylpiracetam can increase the number of receptors for:
As a result, the efficiency of nerve impulse transmission between neurons improves. This specific property may explain the drug's positive impact on memory, learning speed, focus, and the ability to process information quickly.
Like other representatives of the racetam group, Phenylpiracetam positively affects cerebral blood flow. It is suggested to enhance microcirculation and support normal blood flow in brain tissues.
Better blood circulation means more efficient delivery of oxygen and nutrients to nerve cells. This is particularly crucial during intense mental activity when the brain's energy demands increase significantly.
An improved oxygen supply to the brain can positively affect focus, thinking speed, cognitive endurance, and overall productivity.
In addition to its stimulating effect, Phenylpiracetam demonstrates another interesting property—a potential ability to reduce anxiety levels and improve emotional state.
Experimental studies in animals have shown that the drug can influence GABA, acetylcholine, and NMDA receptors, which are involved in regulating emotional responses. As a result, a reduction in signs of fear and anxiety was observed without the development of a pronounced sedative effect.
Unlike classic tranquilizers, Phenylpiracetam does not cause excessive drowsiness or sluggishness, thereby not hindering intellectual work performance.
Over the years, natural changes occur in the body that affect the operation of the central nervous system. The activity of certain neurotransmitters decreases, the metabolism of nerve cells slows down, and the blood supply to the brain gradually deteriorates.
Such processes can manifest not only in old age. Due to chronic stress, sleep deprivation, intense studying, or constant mental workload, similar symptoms are increasingly occurring in young people as well.
The most common changes include:
In daily life, this can manifest as difficulties in remembering new information, slower decision-making, forgetfulness, rapid fatigue, and reduced productivity.
Phenylpiracetam was created precisely to support cognitive functions. Its mechanism of action is aimed not just at temporarily stimulating brain activity, but also at improving the operational efficiency of neurons and neurotransmitter systems.
Phenylpiracetam is considered one of the most powerful representatives of the racetam group due to its high bioavailability and complex effect on the nervous system. After ingestion, the substance is rapidly absorbed, easily crosses the blood-brain barrier, and begins interacting with the brain's neurotransmitter systems.
Unlike many other nootropics, Phenylpiracetam's action extends beyond cognitive functions to physical performance, stress resilience, and overall well-being.
One of the most thoroughly researched properties of the drug is its positive impact on learning and information retention processes. By improving the interaction between neurons, the brain more effectively forms new neural connections necessary for storing and recalling information.
Many users report that after a course of use, new material is absorbed faster, and the need to repeatedly re-read text or restate information is significantly reduced.
Improvements are also noted in:
Phenylpiracetam is frequently used during periods of intense mental work. Thanks to the stimulation of neurotransmitter systems, it helps maintain concentration on a single task longer without feeling depleted.
Users often describe this effect as a state of deep engagement in work, where external distractions are much less disruptive and productivity increases noticeably.
One of the most common descriptions of Phenylpiracetam's action is the clearance of so-called "brain fog." After taking it, information is perceived more easily, and the process of analysis and decision-making occurs faster.
This is why the drug has gained popularity among students, programmers, scientists, managers, and other professionals whose activities involve a high cognitive load.
Through its influence on the dopamine system, Phenylpiracetam can positively affect intrinsic motivation. Many people note that it becomes easier for them to start complex tasks, maintain focus for extended periods, and see their work through to completion.
Reviews often mention a so-called "maximum productivity mode," where complex projects are completed without the usual procrastination.
Unlike most nootropic agents, Phenylpiracetam is capable of affecting not just brain function but physical endurance as well.
The following effects have been noted in research and practical application:
An interesting feature of Phenylpiracetam is its potential impact on the body's adaptation to low temperatures.
Early studies reported that the drug could help individuals tolerate cold climates and extreme temperature conditions more easily. This is why it was studied during the development of performance support programs for astronauts and people working in challenging climatic environments.
The experience of using Phenylpiracetam can vary depending on individual body characteristics, but many users describe similar changes in well-being.
Most frequently reported are:
Some users note that when reading complex materials, there is no longer a need to re-read the same paragraph multiple times. Information is absorbed faster, and attention remains locked onto a single task longer.
An improvement in typing speed, motor coordination, and overall precision in daily actions is also frequently observed.
Some users report a reduction in symptoms of low mood and easier communication with others. Increased self-confidence can positively affect social activity, simplify communication, and reduce psychological discomfort in stressful situations.
Phenylpiracetam is often used as a component in pre-workout complexes. The reason is its ability to increase endurance, maintain high energy levels, and reduce the sensation of physical fatigue during intense workouts.
It is this combination of cognitive and physical effects that has made the drug one of the most famous representatives of the racetam class.
Phenylpiracetam was synthesized in 1983, and most scientific papers dedicated to its study were conducted in Russia and Eastern European countries. Because of this, a significant portion of publications was printed in Russian and remained poorly accessible to the international scientific community for a long time.
Consequently, the number of large-scale, double-blind, placebo-controlled trials following international standards remains limited. At the same time, published clinical works and accumulated practical experience allow for an assessment of the drug's potential properties.
One clinical study evaluated the impact of Phenylpiracetam on individuals aged 40 to 60 who experienced cognitive impairments following surgical interventions or traumatic brain injuries.
Participants received 200 mg of the drug daily for 30 days. Upon completion of the course, researchers recorded positive changes in several areas.
Among the main results noted were:
The results obtained suggest the potential efficacy of the drug as a means of supporting cognitive functions during the recovery period after neurological injuries. However, large-scale international studies are required to definitively confirm these properties.
Another study was conducted involving 400 patients who had suffered an ischemic stroke—the most common type of cerebrovascular accident, which occurs due to the blockage of a blood vessel by a clot.
Participants were divided into two groups.
At the end of the study, the group receiving Phenylpiracetam showed more pronounced recovery of cognitive functions and a faster return to daily activities compared to the control group.
A separate area of research concerns the potential use of Phenylpiracetam in patients with epilepsy.
An epileptic seizure occurs due to sudden, abnormal electrical activity of neurons in the brain. At this moment, normal transmission of nerve impulses is disrupted, which can lead to convulsions, loss of consciousness, or other neurological symptoms.
In animal experiments, it was established that Phenylpiracetam could influence the alpha and beta rhythms of the brain. In addition, researchers drew attention to its potential anticonvulsant activity.
Some clinical papers reported:
Aside from clinical studies, the practical experience of individuals who have used Phenylpiracetam to improve cognitive functions is of significant interest.
Most frequently reported positive changes include:
At the same time, users also point out the rapid development of tolerance. With daily use, the drug's effectiveness gradually declines, so many people use it only on days when maximum focus or elevated mental productivity is required.
In most clinical trials and practical recommendations, Phenylpiracetam was used in relatively small doses. Due to its high bioavailability, the drug demonstrates a pronounced effect even at doses of 100–200 mg.
The following application schedule is most commonly recommended:
| Parameter | Recommendation |
|---|---|
| Single dose | 100 mg |
| Frequency of intake | 2 times a day |
| Time of intake | In the morning and early afternoon |
| Preferred combination | Along with a choline source (Alpha GPC or CDP-Choline) |
Due to its stimulating properties, it is undesirable to take the drug in the evening. Late intake can make falling asleep difficult or degrade sleep quality.
Many users take Phenylpiracetam only on days of increased mental or physical workload. This approach allows its efficacy to be preserved longer and reduces the risk of tolerance development.
One of Phenylpiracetam's characteristics is the rather rapid development of tolerance to its effects. With continuous daily use, the stimulating action gradually weakens.
For this reason, one of the following schedules is often recommended:
Such schedules are primarily based on the practical experience of users and are not universal medical recommendations.
According to available research, Phenylpiracetam has low toxicity and is generally well tolerated by most healthy adults when recommended doses are respected.
However, like any biologically active substance, it can cause adverse reactions.
The most common complaint among users is a headache. It is believed to be linked to increased utilization of acetylcholine in the brain.
This is why many people combine Phenylpiracetam with choline sources, specifically:
Such a combination can not only reduce the risk of a headache but also potentially enhance the nootropic effect.
Due to its stimulating properties, taking the drug in the evening can cause difficulties falling asleep or shallow sleep.
To minimize this risk, the last dose is recommended to be taken no later than the first half of the day.
One of Phenylpiracetam's primary drawbacks is the rapid build-up of tolerance.
With regular use, the body gradually adapts to the drug's action, causing its efficacy to drop. This is why many experienced users do not take Phenylpiracetam daily.
In some experimental studies on animals, a decrease in body weight gain was reported in obese rodents.
However, there is currently no conclusive clinical evidence that a similar effect occurs in humans. Therefore, using Phenylpiracetam as a weight loss agent is not recommended.
The most common combination is pairing Phenylpiracetam with choline sources.
The reason is that the drug increases the activity of the cholinergic system, and an additional supply of choline can provide sufficient substrate for acetylcholine synthesis.
Most frequently used are:
Some users report a more pronounced improvement in memory and focus precisely with this combination.
Several commercial forms of the drug can be found on the market:
The most widespread form is a dosage of 100 mg per tablet or capsule, which matches the most frequently used administration schedules.
Phenylpiracetam belongs to the most potent representatives of the racetam class and combines nootropic properties with a moderate stimulating effect.
Thanks to its high bioavailability, it effectively penetrates brain tissues and can positively influence memory, focus, processing speed, motivation, and physical performance.
Research results indicate a potential positive effect of the drug on cognitive functions, rehabilitation after certain neurological impairments, and even a reduction in the frequency of epileptic seizures. However, a significant portion of available data was obtained in relatively small studies, meaning additional clinical trials are necessary to definitively confirm its efficacy.
It is also important to consider the rapid development of tolerance, which leads many users to take Phenylpiracetam only as needed or in cycles with breaks.
This material is purely informative in nature and does not constitute medical advice. Before using Phenylpiracetam or any other nootropic supplements, it is necessary to consult a physician, especially in the presence of chronic diseases, epilepsy, cardiovascular pathologies, during pregnancy, or while taking other medications.
The efficacy of Phenylpiracetam is explained not by a single mechanism of action, but by a complex effect on several key brain systems. Thanks to this, the drug can simultaneously improve cognitive functions, increase mental productivity, and positively influence physical endurance.
Acetylcholine is one of the most important neurotransmitters responsible for learning, focus, the formation of new memories, and information processing speed.
According to experimental study data, Phenylpiracetam can increase the density of acetylcholine receptors. As a result, neurons respond more effectively even to a normal amount of acetylcholine, potentially contributing to the improvement of cognitive functions.
This is why adding choline sources is often recommended during the administration of the drug, as the brain's demand for acetylcholine can increase.
Dopamine is involved in shaping motivation, feelings of reward, the ability to focus, and maintaining high work capacity.
It is hypothesized that Phenylpiracetam increases the efficiency of dopamine receptors. This can explain the boost in motivation, the desire to take on complex tasks, and the growth in overall productivity.
The drug does not cause a sharp spike in dopamine levels. Its action consists rather in optimizing the operation of already existing neurotransmitter systems.
Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter of the central nervous system. It helps maintain the balance between excitation and inhibition processes, promoting emotional stability.
An increase in GABA receptor activity may explain user reports of reduced internal tension, easier stress management, and improved emotional state without pronounced drowsiness.
NMDA receptors play an important role in neuroplasticity—the brain's ability to form new neural connections.
These processes form the baseline for learning, long-term memory, and the brain's adaptation to new information.
It is believed that Phenylpiracetam can positively influence NMDA receptor activity, supporting memory retention and learning processes.
Most nootropics are primarily oriented toward improving cognitive functions. Phenylpiracetam is an exception, as its action extends to physical work capacity as well.
It is this feature that made the drug famous far beyond the bounds of medicine.
Various studies have reported:
